To assess WT1-specificity in hematological cancers via TCRGP models, we compiled TCRβ cohorts of healthy donors, AML, MDS, and CML patients and single-cell RNA + TCRαβ cohorts of AML and CML patients (Table 1), as described in Materials and Methods. The gene discussed is WT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.